Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

JAMA Internal Medicine Author Interviews

Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

Interviews with authors of articles from JAMA Internal Medicine. JAMA Internal Medicine is an international peer-reviewed journal providing innovative and clinically relevant research for practitioners in general internal medicine and internal medicine subspecialties. We strive to publish articles that are stimulating to read, educate and inform readers with the most up-to-date research, and lead to positive change in our health care systems and the way we deliver patient care.

About

JAMA Internal Medicine Author Interviews